MGMT and glioblastoma: Second, advanced multiparametric MRI including GRE-DSC perfusion have shown to correlate with IDH-mutation and MGMT promoter methylation status in glioblastomas,30 reinforcing NVM’s potential beyond quantitative perfusion estimates to provide biologically relevant imaging biomarkers that may aid in noninvasive tumor classification.